Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FC087
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,573
Award facts
- Contract value 100% obligated
- $36,572.76 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $36,572.76 with a firm fixed-price structure, was awarded on January 30, 2026, to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) by the Defense Logistics Agency. The contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This prime IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026.
AmerisourceBergen Drug Corp functions as a critical vendor within the federal medical procurement ecosystem, supplying essential pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to efficiently fulfill government requirements for medications spanning oncology, diabetes, neurological conditions, pain management, and other specialized medical treatments. DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen among the key contractors supporting military and federal healthcare supply chains.
Quick answers
Who was awarded contract SPE2DU26FC087?
SPE2DU26FC087 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DU26FC087 worth?
The government has obligated $36,573 on SPE2DU26FC087.
Is contract SPE2DU26FC087 an order under another contract?
Yes. SPE2DU26FC087 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FC087 competed?
The extent of competition for SPE2DU26FC087 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award